Sign in

CIK 0000811641

  • Non-accelerated filer
  • Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010382980
Phone
+1 207-878-2770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 4 Open-market buy Director bought 2,312 shares at an average $3.83 ($8,850)
  2. 4 Open-market buy Director bought 1,600 shares at an average $3.79 ($6,063)
  3. 4 Open-market buy Director bought 1,765 shares at an average $3.91 ($6,902)
  4. 4 Open-market buy Director bought 7,764 shares at an average $2.14 ($16,643)
  5. 4 Open-market buy Director bought 4,850 shares at an average $2.01 ($9,748)
  6. 4 Open-market buy Director bought 300 shares at $1.88 ($564)
  7. 4 Open-market buy Director bought 400 shares at $1.81 ($724)
  8. 4 Open-market buy Director bought 700 shares at an average $1.85 ($1,297)
  9. 4 Open-market buy Director bought 2,175 shares at an average $1.89 ($4,105)
  10. 4 Open-market buy Vice President & CSO bought 23,000 shares at $1.31 ($30,188)
  11. 4 Open-market buy President & CEO bought 51,000 shares at $1.31 ($66,938)
  12. 4 Open-market buy Director bought 400 shares at $2.00 ($800)
  13. 4/A Open-market buy Director bought 300 shares at $2.00 ($600)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy Director bought 6,000 shares at $1.81 ($10,860)
  17. 4 Open-market buy Director bought 5,070 shares at an average $1.80 ($9,133)
  18. 4 Open-market buy Director bought 500 shares at $2.50 ($1,250)
  19. 4 Open-market buy Director bought 100 shares at $3.35 ($335)
  20. 4 Open-market buy Director bought 1,200 shares at $3.45 ($4,140)

Page 9 of 13 · 256 filings